JOSEPH RUBINO: Open Payments
NPI 1700658341 · LANGHORNE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$702 in 31 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $755 · 2025 $702
Food & beverage: $702
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 11 | $196 |
| ABBVIE INC. | 4 | $113 |
| Janssen Biotech, Inc. | 3 | $65 |
| ConvaTec Inc. | 1 | $59 |
| Endo USA, Inc. | 3 | $54 |
| Sumitomo Pharma America, Inc. | 2 | $51 |
| Procept Biorobotics Corporation | 2 | $39 |
| Astellas Pharma US Inc | 1 | $34 |
| Antares Pharma, Inc. | 1 | $27 |
| Smith+Nephew, Inc. | 1 | $22 |
Products named: INTERSTIM, BOTOX, ERLEADA, GENTLECATH GLIDE, XIAFLEX, GEMTESA, AQUABEAM ROBOTIC SYSTEM, Xtandi.
Industry payments across PA — which companies pay providers there.
